✦ LIBER ✦

Debate: is adefovir a first line nucleoside analog for treatment of chronic hepatitis B

✍ Scribed by CHING LUNG LAI

Book ID: 108950081
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 32 KB
Volume: 19
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2004.03658.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid HBV DNA decrease (week 12) is an i

Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B

✍ Holger G. Hass; Thomas Bock; Oliver Nehls; Stephan Kaiser 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 291 KB

Adefovir dipivoxil monotherapy is a suff

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

✍ Ken Sato; Hitoshi Takagi; Satoru Kakizaki; Naondo Sohara; Masatomo Mori 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 61 KB

Adefovir dipivoxil monotherapy is a suff

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

✍ Ken Sato; Hitoshi Takagi; Satoru Kakizaki; Naondo Sohara; Masatomo Mori 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 199 KB

Review article: nucleoside analogues for

Review article: nucleoside analogues for the treatment of chronic hepatitis B

✍ H. M. Younger; A. J. Bathgate; P. C. Hayes 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

A Systematic Review of Side Effects of N

A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B

✍ Vandana Khungar; Steven-Huy Han 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 217 KB

Although nucleosides and nucleotides have a good safety record for the treatment of hepatitis B, there have been no systematic reviews on this topic. We searched Medline to include studies of the oral antiviral agents for hepatitis B and adverse events, with at least 48 weeks of follow-up from the i

A systematic review and economic evaluat

A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B

✍ A. Takeda; J. Jones; J. Shepherd; P. Davidson; A. Price 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB